Hemab Therapeutics Holdings, Inc. Common Stock (COAG) vs Innoviva, Inc. (INVA)

A side-by-side comparison of Hemab Therapeutics Holdings, Inc. Common Stock and Innoviva, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Hemab Therapeutics Holdings, Inc. Common Stock logo
COAG
Hemab Therapeutics Holdings, Inc. Common Stock
$1.34B
$28.73HealthcareDelayed quote: Oct 6, 2026, 2:55 PM EDT
Innoviva, Inc. logo
INVA
Innoviva, Inc.
$1.54B
$20.90HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT

Total return — COAG vs INVA

growth of $100 · dividends reinvested · last 1y
COAG -10.0% (-10.0%/yr)INVA -12.9% (-12.9%/yr)COAG compounded faster over this window
80100120140160Start $100$90$87
COAG INVA

COAG vs INVA: by the numbers

  • •INVA is the larger company ($1.54B vs $1.34B market cap).
  • •INVA is profitable (80.56% net margin) while COAG runs a net loss (0.00%).

Metrics side by side

Valuation

MetricCOAGINVA
P/E ratioN/A5.10
Forward P/EN/A8.64
PEG ratioN/A0.49
P/S ratioN/A3.48
P/B ratio2.951.25
EV / EBITDAN/A4.92
FCF yieldN/A12.21%

Profitability

MetricCOAGINVA
Gross margin0.00%73.09%
Operating margin0.00%36.66%
Net margin0.00%80.56%
ROEN/A28.97%
ROIC-38.09%8.36%

Growth (annualized)

MetricCOAGINVA
Revenue CAGR (5Y)N/A3.94%
EPS CAGR (5Y)N/A12.71%
FCF CAGR (5Y)N/A-10.54%
Total return CAGR (5Y)N/A4.52%

Frequently asked

Is COAG or INVA more profitable?
INVA runs the higher net margin — COAG at 0.00% versus INVA at 80.56%.

Go deeper

Full COAG analysisFull INVA analysisInteractive comparison tool

Dig into the metrics

Innoviva P/E ratioHemab Therapeutics Holdings, Inc. Common Stock ROEInnoviva ROEHemab Therapeutics Holdings, Inc. Common Stock operating marginInnoviva operating marginHemab Therapeutics Holdings, Inc. Common Stock revenue growthInnoviva revenue growthHemab Therapeutics Holdings, Inc. Common Stock free cash flowInnoviva free cash flow

Hemab Therapeutics Holdings, Inc. Common Stock & Innoviva appear in these rankings

Highest ROE StocksHighest Operating Margin StocksHighest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.